My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 164

    1.

    Role of the fatty acid binding protein mal1 in obesity and insulin resistance.

    Maeda K, Uysal KT, Makowski L, Görgün CZ, Atsumi G, Parker RA, Brüning J, Hertzel AV, Bernlohr DA, Hotamisligil GS.

    Diabetes. 2003 Feb;52(2):300-7.PMID: 12540600 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice.

    Boord JB, Maeda K, Makowski L, Babaev VR, Fazio S, Linton MF, Hotamisligil GS.

    Circulation. 2004 Sep 14;110(11):1492-8. Epub 2004 Sep 7.PMID: 15353487 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Regulation of metabolic responses by adipocyte/macrophage Fatty Acid-binding proteins in leptin-deficient mice.

    Cao H, Maeda K, Gorgun CZ, Kim HJ, Park SY, Shulman GI, Kim JK, Hotamisligil GS.

    Diabetes. 2006 Jul;55(7):1915-22.PMID: 16804058 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes.

    Maeda K, Cao H, Kono K, Gorgun CZ, Furuhashi M, Uysal KT, Cao Q, Atsumi G, Malone H, Krishnan B, Minokoshi Y, Kahn BB, Parker RA, Hotamisligil GS.

    Cell Metab. 2005 Feb;1(2):107-19.PMID: 16054052 [PubMed - indexed for MEDLINE]Related articles

    5.

    Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice.

    Furuhashi M, Fucho R, Görgün CZ, Tuncman G, Cao H, Hotamisligil GS.

    J Clin Invest. 2008 Jul;118(7):2640-50.PMID: 18551191 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein.

    Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM.

    Science. 1996 Nov 22;274(5291):1377-9.PMID: 8910278 [PubMed - indexed for MEDLINE]Related articles

    7.

    Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis.

    Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, Parker RA, Suttles J, Fazio S, Hotamisligil GS, Linton MF.

    Nat Med. 2001 Jun;7(6):699-705.PMID: 11385507 [PubMed - indexed for MEDLINE]Related articles

    8.

    Improved glucose and lipid metabolism in genetically obese mice lacking aP2.

    Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS.

    Endocrinology. 2000 Sep;141(9):3388-96.PMID: 10965911 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Increased lipolysis in transgenic animals overexpressing the epithelial fatty acid binding protein in adipose cells.

    Hertzel AV, Bennaars-Eiden A, Bernlohr DA.

    J Lipid Res. 2002 Dec;43(12):2105-11.PMID: 12454272 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Lipid metabolism and adipokine levels in fatty acid-binding protein null and transgenic mice.

    Hertzel AV, Smith LA, Berg AH, Cline GW, Shulman GI, Scherer PE, Bernlohr DA.

    Am J Physiol Endocrinol Metab. 2006 May;290(5):E814-23. Epub 2005 Nov 22.PMID: 16303844 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Adipocyte metabolism in adipocyte fatty acid binding protein knockout mice (aP2-/-) after short-term high-fat feeding: functional compensation by the keratinocyte [correction of keritinocyte] fatty acid binding protein.

    Shaughnessy S, Smith ER, Kodukula S, Storch J, Fried SK.

    Diabetes. 2000 Jun;49(6):904-11. Erratum in: Diabetes 2000 Sep;49(9):1617. PMID: 10866041 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice.

    Scheja L, Makowski L, Uysal KT, Wiesbrock SM, Shimshek DR, Meyers DS, Morgan M, Parker RA, Hotamisligil GS.

    Diabetes. 1999 Oct;48(10):1987-94.PMID: 10512363 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity.

    Kershaw EE, Morton NM, Dhillon H, Ramage L, Seckl JR, Flier JS.

    Diabetes. 2005 Apr;54(4):1023-31.PMID: 15793240 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease.

    Tuncman G, Erbay E, Hom X, De Vivo I, Campos H, Rimm EB, Hotamisligil GS.

    Proc Natl Acad Sci U S A. 2006 May 2;103(18):6970-5. Epub 2006 Apr 25.PMID: 16641093 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Adipocyte/macrophage fatty acid binding proteins in metabolic syndrome.

    Erbay E, Cao H, Hotamisligil GS.

    Curr Atheroscler Rep. 2007 Sep;9(3):222-9. Review.PMID: 18241617 [PubMed - indexed for MEDLINE]Related articles

    16.

    Resistance to diet-induced obesity and improved insulin sensitivity in mice with a regulator of G protein signaling-insensitive G184S Gnai2 allele.

    Huang X, Charbeneau RA, Fu Y, Kaur K, Gerin I, MacDougald OA, Neubig RR.

    Diabetes. 2008 Jan;57(1):77-85. Epub 2007 Oct 10.PMID: 17928396 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels.

    Coe NR, Simpson MA, Bernlohr DA.

    J Lipid Res. 1999 May;40(5):967-72.PMID: 10224167 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity.

    Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J, Thomas G.

    Nature. 2004 Sep 9;431(7005):200-5. Epub 2004 Aug 11. Erratum in: Nature. 2004 Sep 23;431(7007):485. PMID: 15306821 [PubMed - indexed for MEDLINE]Related articles

    19.

    Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1.

    Lijnen HR, Maquoi E, Morange P, Voros G, Van Hoef B, Kopp F, Collen D, Juhan-Vague I, Alessi MC.

    Arterioscler Thromb Vasc Biol. 2003 Jan 1;23(1):78-84.PMID: 12524228 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.

    Ma LJ, Mao SL, Taylor KL, Kanjanabuch T, Guan Y, Zhang Y, Brown NJ, Swift LL, McGuinness OP, Wasserman DH, Vaughan DE, Fogo AB.

    Diabetes. 2004 Feb;53(2):336-46.PMID: 14747283 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity